RATIO THERAPEUTICS Trademark
Trademark Overview
On Wednesday, October 16, 2024, a trademark application was filed for RATIO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RATIO THERAPEUTICS trademark a serial number of 98804636. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, October 16, 2024. This trademark is owned by Ratio Therapeutics, Inc.. The RATIO THERAPEUTICS trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use.
Small molecule chemical structures, namely, reagents for adhering radioactive agents to pharmaceutical compounds for chelating radioisotopes for scientific purposes; chemical agents for chelating radioisotopes.
General Information
Serial Number | 98804636 |
Word Mark | RATIO THERAPEUTICS |
Filing Date | Wednesday, October 16, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Wednesday, October 16, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Description of Mark | The mark consists of The word "ratio" above the word "therapeutics" with a spiral originating above the "t" and curling to the right of the words with a grid pattern under the spiral. |
Goods and Services | Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Small molecule chemical structures, namely, reagents for adhering radioactive agents to pharmaceutical compounds for chelating radioisotopes for scientific purposes; chemical agents for chelating radioisotopes. |
NOT AVAILABLE | "therapeutics" |
Classification Information
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 16, 2024 |
Primary Code | 001 |
First Use Anywhere Date | Thursday, July 7, 2022 |
First Use In Commerce Date | Sunday, July 17, 2022 |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 16, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Wednesday, May 31, 2023 |
First Use In Commerce Date | Wednesday, May 31, 2023 |
Trademark Owner History
Party Name | Ratio Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Boston, MA 02210 |
Trademark Events
Event Date | Event Description |
Wednesday, October 16, 2024 | NEW APPLICATION ENTERED |
Thursday, April 10, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, April 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |